Vela Diagnostics Vela Diagnostics, National Cancer Center of Singapore to Develop CDx for EGFR-TKI Therapies Vela Diagnostics and NCCS will evaluate the efficacy of the assay in a clinical trial to test the response of patients to EGFR-TKI therapies. Vela Diagnostics Receives Second FDA Emergency Use Authorization for SARS-CoV-2 Molecular Test The second EUA for a test that targets the ORF1a and N genes is for an automated version of a manual test that had been granted EUA in August. Vela Diagnostics, Capstone Healthcare Get FDA Emergency Use Authorization for Coronavirus Tests The Vela and Capstone tests are both PCR-based and designed to detect their viral RNA targets in nasopharyngeal and oropharyngeal swab specimens. Vela Diagnostics Automated Coronavirus Test Gets CE-IVD Mark Vela Diagnostics said that the RT-PCR-based test has also received provisional authorization from the Health Sciences Authority in Singapore. Vela Diagnostics, JN Medsys Get CE-IVD Marks for Coronavirus Tests Vela anticipates CE-IVD marking for an automated version of its test, and JN Medsys has received authorization for its test in Singapore and the Philippines. Apr 20, 2020 Vela Diagnostics Awarded BARDA Funding for COVID-19 Test Apr 16, 2020 Vela Diagnostics Coronavirus RT-PCR Test Provisionally Authorized by Singapore Regulator Feb 7, 2020 In Brief This Week: LineaRx, OncoCyte, Vela Diagnostics, CosmosID, More Nov 5, 2019 FDA Authorizes Marketing of Vela Diagnostics NGS-Based HIV-1 Drug Resistance Mutation Test Mar 26, 2019 Vela Diagnostics Submits NGS HIV Genotyping, Drug Resistance Assay to FDA Jul 23, 2018 Vela Diagnostics Accelerates Entry Into US Microbiology Market With Great Basin Buy Premium Jun 25, 2018 Vela Diagnostics Buys Great Basin Scientific Aug 18, 2017 Great Basin in Default of Senior Notes for $18.3M Jul 13, 2017 Great Basin Receives FDA Clearance for Stool Bacterial Pathogens Panel Jun 22, 2017 Great Basin Closes $2.1M Offering Jun 20, 2017 Great Basin Scientific Prices $2.7M Securities Offering May 23, 2017 Great Basin Plans to Raise $3.5M May 22, 2017 Great Basin Reports 14 Percent Revenue Growth in Q1 May 16, 2017 Great Basin Whooping Cough Test Gets CE Marking May 12, 2017 In Brief This Week: Alere, Fulgent Diagnostics, Trovagene, Great Basin, and More Apr 12, 2017 Great Basin Gets CE Mark for Stool Pathogens Panel Apr 10, 2017 Great Basin Restructures Convertible Securities, Gaining Access to Cash Apr 3, 2017 Great Basin Whooping Cough MDx Clears FDA Mar 22, 2017 Great Basin Q4 Revenues Rise 39 Percent Feb 14, 2017 Great Basin Files to Raise $10M Load More Breaking News In Brief This Week: Illumina, Personalis, Proteomedix, and More Ancient DNA Details Population Dynamics Within Andean Tiwanaku Civilization Genomic Data Spanning 2K Years Gives Glimpse of Etruscan Origins, Population Changes People in the News: New Appointments at Hologic, Akoya Biosciences, Caris Life Sciences, More At NSGC, Genetic Counselors Address Race-Based Medicine, Ways to Change New Products Posted to GenomeWeb: Becton Dickinson, Cosmos-ID, OncoDNA, More The Scan US Booster Eligibility Decision The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions. Arizona Bill Before Judge The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction. Additional Genes Wales is rolling out new genetic testing service for cancer patients, according to BBC News. Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.